PAXALISIB

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H22N8O2
Molecular Weight	382.4197
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC1(C)OCCN2C1=NC3=C2N=C(N=C3N4CCOCC4)C5=CN=C(N)N=C5

InChI

InChIKey=LGWACEZVCMBSKW-UHFFFAOYSA-N

InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21)

HIDE SMILES / InChI

Molecular Formula	C18H22N8O2
Molecular Weight	382.4197
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
PI3-kinase p110-alpha subunit 41	Inhibitor 8,297		2.0 nM [IC50]
Serine/threonine-protein kinase mTOR 35	Inhibitor 8,297		0.07 µM [IC50]

C_max

Value	Dose	Co-administered	Analyte	Population
0.51 μM	45 mg 1 times / day multiple, oral		GDC-0084 plasma	Homo sapiens

AUC

Value	Dose	Co-administered	Analyte	Population
8.48 μM × h	45 mg 1 times / day multiple, oral		GDC-0084 plasma	Homo sapiens

T_1/2

Value	Dose	Co-administered	Analyte	Population
15.3 h	45 mg 1 times / day multiple, oral		GDC-0084 plasma	Homo sapiens

Substance Class	Chemical
Record UNII	P5DKZ70636
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

PAXALISIB

Official Name

English

GDC-0084

Preferred Name

English

5-(6,6-DIMETHYL-4-MORPHOLINO-8,9-DIHYDRO-6H-(1,4)OXAZINO(3,4-E)PURIN-2-YL)PYRIMIDIN-2-AMINE

Systematic Name

English

PAXALISIB [USAN]

Common Name

English

G-02441729

Code

English

Showing 1 to 5 of 13 entries

Previous1 2 3Next

Show entries

Classification Tree

Code System

Code

Designated

FDA ORPHAN DRUG

759220

Designated

FDA ORPHAN DRUG

624217

Designated

FDA ORPHAN DRUG

892422

Showing 1 to 3 of 3 entries

Previous1Next

Show entries

Code System

Code

Type

Description

NCI_THESAURUS

C116877

PRIMARY

FDA UNII

P5DKZ70636

PRIMARY

CAS

1382979-44-3

PRIMARY

INN

11102

PRIMARY

SMS_ID

300000010831

PRIMARY

Showing 1 to 5 of 8 entries

Previous1 2Next

Show entries

Related Record

Type

Details


					JQ83GG8LT2

PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT ALPHA ISOFORM

TARGET -> INHIBITOR

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					P5DKZ70636

PAXALISIB

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Name	Property Type	Amount	Parameters
BRAIN/PLASMA RATIO	PHARMACOKINETIC	MOL RATIO 1.4 (average)	MEASUREMENT PHARMACOKINETIC TOTAL SPECIES BIOLOGICAL MOUSE

BRAIN/PLASMA RATIO	PHARMACOKINETIC	MOL RATIO 0.4 (average)	SPECIES BIOLOGICAL MOUSE MEASUREMENT PHARMACOKINETIC FREE

SMILES

InChI

Approval Year

Targets

Cmax

AUC

T1/2

C_max

T_1/2